Vaccinology During and After COVID-19
COVID-19 期间和之后的疫苗学
基本信息
- 批准号:10753782
- 负责人:
- 金额:$ 0.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-20 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAffectAntibody ResponseB-LymphocytesCOVID-19COVID-19 impactCOVID-19 pandemicCOVID-19 vaccineClinical MedicineCollaborationsCommunicable DiseasesDevelopmentDimensionsEconomicsEducational workshopEnsureEquityEthicsFutureHumanImmunityImmunologyIndustrializationInequalityInternationalInvestmentsKnowledgeLearningLicensingMedicalMentorsMethodologyMicrobiologyOutcomePharmaceutical PreparationsPoliticsPrivatizationPublic HealthRNA vaccineRecording of previous eventsResearchResearch PersonnelScienceScientistSmallpoxSociologySpeedSurveysSystems BiologyT-LymphocyteTechnologyTestingTimeTranslationsVaccinationVaccinesVirusclinical implementationclinical practicecombatdesignfuture pandemicglobal healthimprovedinnovationinterestmultidisciplinarynew technologynovel therapeuticspandemic diseasepandemic preparednesspathogenpost-COVID-19postersprospectivestructural biologysymposiumvaccine accessvaccine distributionvaccine platformvaccinologyvirtual
项目摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Vaccinology During and After COVID-19,
organized by Drs. Bali Pulendran, Robert Seder and Gagandeep Kang. The conference will be held in Atlanta,
Georgia from September 17-21, 2023.
Since its emergence, SARS-CoV-2 has radically transformed practically every dimension of our lives and
fueled an urgent global imperative to develop safe and effective vaccines. The stunning pace at which COVID-
19 vaccines have been developed is unprecedented in the history of vaccinology and has been catalyzed by
the rapid harnessing of innovative new technologies (e.g., mRNA vaccines) and major public and private
investments. The COVID-19 pandemic offered a unique vantage point from which to survey vaccinology as it
was for the past two centuries, since Edward Jenner and the eradication of smallpox, to how it is now, during
the time of COVID-19, and to consider what it could be in the post-COVID era. Equally important has been the
world’s focus on the economics, politics and ethics of how to ensure global equitable access to COVID-19
vaccines. This virus has certainly shone a spotlight on the field of vaccinology as it is, at the focal point of
immunology, microbiology, public health, clinical medicine, economics, sociology, ethics and international
diplomacy. Thus, some talks will also be focused on these broader issues surrounding the field. It is anticipated
that this conference will stimulate debate that helps enhance pandemic preparedness by redefining the way we
conceive of, make, test, license and distribute vaccines globally. Overall, this conference is designed to bring
together an interdisciplinary team of experts to discuss the lessons learnt from the COVID-19 pandemic, with a
particular focus on the immunology of vaccination.
抽象的
要求在Covid-19期间和之后举行的Keystone研讨会会议,题为疫苗。
由Drs组织。 Bali Pulendran,Robert Seder和Gagandeep Kang。会议将在亚特兰大举行
佐治亚州从2023年9月17日至21日。
自从出现以来,SARS-COV-2从根本上改变了我们生活的每个维度,
加剧了紧急的全球当务之急,以开发安全有效的疫苗。 COVID的惊人空间
19在疫苗学史上已经开发了19疫苗,并被催化
快速利用创新的新技术(例如mRNA疫苗)和主要的公共和私人
投资。 COVID-19大流行提供了一个独特的有利位置,可以从中调查疫苗学。
自从爱德华·詹纳(Edward Jenner)和天花的根除以来,过去两个世纪以来
Covid-19的时代,并考虑到后时代可能是什么。同样重要的是
世界上关注如何确保全球公平访问Covid-19的经济学,政治和道德规范
疫苗。这种病毒肯定在疫苗学领域占有关注的焦点。
免疫学,微生物学,公共卫生,临床医学,经济学,社会学,伦理学和国际
外交。这是一些谈判也将集中在围绕该领域的这些更广泛的问题上。预计
这次会议将刺激辩论,从而通过重新定义我们的方式来帮助增强大流行的准备
全球构想,制造,测试,许可和分发疫苗。总体而言,这次会议旨在带来
一个跨学科的专家团队一起讨论了从199大流行中学到的教训,
特别关注疫苗接种免疫学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TERRY L. SHEPPARD其他文献
TERRY L. SHEPPARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TERRY L. SHEPPARD', 18)}}的其他基金
Pulmonary Hypertension: State of the Art and Therapeutic Opportunities
肺动脉高压:最新技术和治疗机会
- 批准号:
10682118 - 财政年份:2023
- 资助金额:
$ 0.75万 - 项目类别:
Infections in Pregnancy: PathogenicMechanisms, Experimental Advances and Clinical Strategies
妊娠期感染:致病机制、实验进展和临床策略
- 批准号:
10540260 - 财政年份:2023
- 资助金额:
$ 0.75万 - 项目类别:
Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade
微生物群-免疫相互作用的机制-迈向下一个十年
- 批准号:
10753451 - 财政年份:2023
- 资助金额:
$ 0.75万 - 项目类别:
Transposable Elements at the Crossroads of Evolution, Health and Disease
处于进化、健康和疾病十字路口的转座元件
- 批准号:
10750852 - 财政年份:2023
- 资助金额:
$ 0.75万 - 项目类别:
Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment
长期新冠肺炎和 SARS CoV 2 (PASC) 急性后遗症:发病机制和治疗
- 批准号:
10749522 - 财政年份:2023
- 资助金额:
$ 0.75万 - 项目类别:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
- 批准号:
10683443 - 财政年份:2023
- 资助金额:
$ 0.75万 - 项目类别:
Inflammation in the Lung: Friend or Foe in Viral Infections?
肺部炎症:病毒感染的朋友还是敌人?
- 批准号:
10681956 - 财政年份:2023
- 资助金额:
$ 0.75万 - 项目类别:
B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics
B 细胞和三级淋巴结构:癌症治疗的新兴靶点
- 批准号:
10754008 - 财政年份:2023
- 资助金额:
$ 0.75万 - 项目类别:
相似国自然基金
SARS-CoV-2 S2蛋白与肠道菌群交叉反应抗体的产生机制及其对新冠肺炎病程和疫苗效果的影响
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
SARS-CoV-2 S2蛋白与肠道菌群交叉反应抗体的产生机制及其对新冠肺炎病程和疫苗效果的影响
- 批准号:32270986
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
新趋化因子PSMP介导的炎症反应对GVHD发生的影响
- 批准号:81601369
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
肾移植受者血清多反应性抗体与HLA抗体的相关性及影响移植肾长期存活的机制
- 批准号:81501381
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
预先存在的免疫力对学生人群甲型H1N1流感发病的影响和变异抗原表位的识别
- 批准号:81302476
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
IAS 2023, the 12th IAS Conference on HIV Science, Brisbane, Australia, and virtually, 23-26 July 2023
IAS 2023,第 12 届 IAS HIV 科学会议,澳大利亚布里斯班,虚拟会议,2023 年 7 月 23-26 日
- 批准号:
10696505 - 财政年份:2023
- 资助金额:
$ 0.75万 - 项目类别:
Infant Immunologic and Neurologic Development following Maternal Infection in Pregnancy during Recent Epidemics
近期流行病期间妊娠期感染后婴儿的免疫和神经系统发育
- 批准号:
10784250 - 财政年份:2023
- 资助金额:
$ 0.75万 - 项目类别:
Immunologic and Clinical Sequelae after COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases
系统性自身免疫性风湿病患者 COVID-19 后的免疫学和临床后遗症
- 批准号:
10583192 - 财政年份:2023
- 资助金额:
$ 0.75万 - 项目类别:
Understanding antibody responses and defining correlates of protection for endemic and pandemic coronavirus strains
了解抗体反应并定义地方性和大流行性冠状病毒株保护的相关性
- 批准号:
10549479 - 财政年份:2023
- 资助金额:
$ 0.75万 - 项目类别:
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2
SARS-CoV-2 急性后肺部后遗症的遗传和免疫炎症驱动因素
- 批准号:
10587075 - 财政年份:2023
- 资助金额:
$ 0.75万 - 项目类别: